Burjeel Holdings has announced the opening of its new Genetics and Rare Disease Center, a pioneering initiative that will offer comprehensive and integrated care to patients suffering from rare and complex genetic diseases in the MENA region.
With an expanding requirement for special treatment in this area, the new center is set to be a regional center for early diagnosis, personalized treatment, and cutting-edge genetic testing. It seeks to fill the most critical gaps in healthcare by providing multidisciplinary care in the form of genetic counseling, clinical trials, and innovative diagnostics.
In discussing the opening, Burjeel Holdings highlighted the mission of the center to provide world-class care near home, eliminating the need for patients to look abroad for treatment. The center also seeks to partner with global institutions in order to drive research and innovation in managing rare diseases.
This move represents a big leap towards improving patient outcomes, improving regional healthcare infrastructure, and raising awareness regarding rare diseases in the Middle East and North Africa.
